Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical PatientsAlexander T Cohen, Victor F. Tapson, Theodore E. Spiro et al.|New England Journal of Medicine|2013Cited by 603
Stroke prevention in atrial fibrillation—An Asian stroke perspectiveHung‐Fat Tse, Dayi Hu, Andreas Clemens et al.|Heart Rhythm|2013Cited by 153
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocolAlexander Thomas Cohen, Victor F. Tapson, Theodore E. Spiro et al.|Journal of Thrombosis and Thrombolysis|2011Cited by 120
D‐dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trialAlexander T. Cohen, Paul Burton, Theodore E. Spiro et al.|Journal of Thrombosis and Haemostasis|2014Cited by 115
Predicting the Risk of Venous Thromboembolism in Patients Hospitalized With Heart FailureAlexandre Mebazaa, Alexander T. Cohen, Lloyd Haskell et al.|Circulation|2014Cited by 70